EMD Serono, Inc.
EMD Serono, Inc. is a leader in the US biopharmaceutical arena, integrating cutting-edge science with unparalleled patient
support systems to improve people’s lives.
EMD Serono is focused on strengthening its position across its core therapeutic areas of neurodegenerative diseases, fertility
and metabolic endocrinology, while growing its presence and expertise within new areas, including oncology and autoimmune
diseases.
EMD Serono recently announced plans to construct a state-of-the-art research facility in Massachusetts, creating critical
mass in research with a common goal of finding new treatments for unmet medical needs.
| Facts and Figures | |
| President and CEO | Fereydoun Firouz |
| Number of employees | 850 |
| Sales | $873 million (2007) |
| Therapeutic areas and major products |
Neurodegenerative Diseases: Rebif (interferon beta-1a)
|
